Jeffrey M. Witkin
Affiliations: | Eli Lilly, Indianapolis, IN, United States |
Google:
"Jeffrey Witkin"Mean distance: 17.34 (cluster 19) | S | N | B | C | P |
Parents
Sign in to add mentorJames E. Barrett | research assistant | University of Maryland | |
Linda A. Dykstra | grad student | UNC Chapel Hill | |
J. David Leander | post-doc | UNC Chapel Hill |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Knopp KL, Simmons RMA, Guo W, et al. (2019) Modulation of TARP γ8-containing AMPA Receptors as a Novel Therapeutic Approach for Chronic Pain. The Journal of Pharmacology and Experimental Therapeutics |
Witkin JM, Shenvi RA, Li X, et al. (2018) Pharmacological characterization of the neurotrophic sesquiterpene jiadifenolide reveals a non-convulsant signature and potential for progression in neurodegenerative disease studies. Biochemical Pharmacology |
Witkin JM, Smith JL, Ping X, et al. (2018) Bioisosteres of ethyl 8-ethynyl-6-(pyridin-2-yl)-4H-benzo[f]imidazo [1,5-a][1,4]diazepine-3-carboxylate (HZ-166) as novel alpha 2,3 selective potentiators of GABA receptors: Improved bioavailability enhances anticonvulsant efficacy. Neuropharmacology. 137: 332-343 |
Methuku KR, Li X, Cerne R, et al. (2018) An antidepressant-related pharmacological signature for positive allosteric modulators of α2/3-containing GABA receptors. Pharmacology, Biochemistry, and Behavior |
Xu NZ, Ernst M, Treven M, et al. (2018) Negative allosteric modulation of alpha 5-containing GABAA receptors engenders antidepressant-like effects and selectively prevents age-associated hyperactivity in tau-depositing mice. Psychopharmacology |
Bruns RF, Mitchell SN, Wafford KA, et al. (2017) Preclinical profile of a dopamine D1 potentiator suggests therapeutic utility in neurological and psychiatric disorders. Neuropharmacology |
Witkin JM, Schober DA, Gleason SD, et al. (2017) Targeted Blockade of TARP-g8-Associated AMPA Receptors: Anticonvulsant Activity with the Selective Antagonist LY3130481 (CERC-611). Cns & Neurological Disorders Drug Targets |
Kato AS, Witkin JM. (2017) Auxiliary subunits of AMPA receptors: the discovery of a forebrain-selective antagonist, LY3130481/CERC-611. Biochemical Pharmacology |
Yuen E, Swanson S, Witkin JM. (2017) Prediction of human efficacious antidepressant doses using the mouse forced swim test. Pharmacology, Biochemistry, and Behavior |
Lee MR, Gardinier KM, Gernert DL, et al. (2017) Structural Determinants of the γ-8 TARP Dependent AMPA Receptor Antagonist. Acs Chemical Neuroscience |